Samuel Kintz insider trades: Enliven Therapeutics (ELVN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Samuel reports to the SEC
Open-market buys and sales
32 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | ELVN | ↓ Sell | 12,500 | $21.82 | $273K | Indirect | Nov 19, 2025 (2d) |
| Oct 17, 2025 | ELVN | ↓ Sell | 12,500 | $21.33 | $267K | Indirect | Oct 21, 2025 (4d) |
| Sep 26, 2025 | ELVN | ↓ Sell | 3,700 | $20.06 | $74K | Indirect | Sep 30, 2025 (4d) |
| Sep 23, 2025 | ELVN | ↓ Sell | 2,800 | $20.03 | $56K | Indirect | Sep 25, 2025 (2d) |
| Sep 19, 2025 | ELVN | ↓ Sell | 6,000 | $19.29 | $116K | Indirect | Sep 19, 2025 (0d) |
| Aug 19, 2025 | ELVN | ↓ Sell | 10,983 | $20.02 | $220K | Indirect | Aug 20, 2025 (1d) |
| Jul 17, 2025 | ELVN | ↓ Sell | 12,500 | $22.52 | $282K | Indirect | Jul 21, 2025 (4d) |
| Jun 17, 2025 | ELVN | ↓ Sell | 12,500 | $22.18 | $277K | Indirect | Jun 18, 2025 (1d) |
| Jun 3, 2025 | ELVN | ↓ Sell | 7,500 | $20.05 | $150K | Indirect | Jun 5, 2025 (2d) |
| May 19, 2025 | ELVN | ↓ Sell | 5,000 | $16.49 | $82K | Indirect | May 21, 2025 (2d) |
| May 2, 2025 | ELVN | ↓ Sell | 7,500 | $20.06 | $150K | Indirect | May 5, 2025 (3d) |
| Apr 17, 2025 | ELVN | ↓ Sell | 5,000 | $16.42 | $82K | Indirect | Apr 21, 2025 (4d) |
| Mar 17, 2025 | ELVN | ↓ Sell | 12,500 | $20.83 | $260K | Indirect | Mar 19, 2025 (2d) |
| Oct 18, 2024 | ELVN | ↓ Sell | 924 | $30.00 | $28K | Indirect | Oct 22, 2024 (4d) |
| Oct 9, 2024 | ELVN | ↓ Sell | 29,977 | $28.07 | $841K | Indirect | Oct 10, 2024 (1d) |
| Oct 7, 2024 | ELVN | ↓ Sell | 14,936 | $27.51 | $411K | Indirect | Oct 8, 2024 (1d) |
| Oct 1, 2024 | ELVN | ↓ Sell | 526 | $27.54 | $14K | Indirect | Oct 3, 2024 (2d) |
| Aug 26, 2024 | ELVN | ↓ Sell | 12,000 | $22.89 | $275K | Indirect | Aug 28, 2024 (2d) |
| Jul 31, 2024 | ELVN | ↓ Sell | 2,270 | $27.56 | $63K | Indirect | Aug 2, 2024 (2d) |
| Jul 25, 2024 | ELVN | ↓ Sell | 12,000 | $24.92 | $299K | Indirect | Jul 29, 2024 (4d) |
| Jun 25, 2024 | ELVN | ↓ Sell | 12,000 | $21.66 | $260K | Indirect | Jun 27, 2024 (2d) |
| May 28, 2024 | ELVN | ↓ Sell | 12,000 | $23.18 | $278K | Direct | May 30, 2024 (2d) |
| Apr 25, 2024 | ELVN | ↓ Sell | 12,000 | $16.89 | $203K | Direct | Apr 29, 2024 (4d) |
| Apr 11, 2024 | ELVN | ↓ Sell | 47,709 | $25.04 | $1.2M | Direct | Apr 15, 2024 (4d) |
| Mar 25, 2024 | ELVN | ↓ Sell | 12,000 | $17.56 | $211K | Direct | Mar 27, 2024 (2d) |
| Feb 26, 2024 | ELVN | ↓ Sell | 12,000 | $16.89 | $203K | Direct | Feb 28, 2024 (2d) |
| Jan 25, 2024 | ELVN | ↓ Sell | 12,000 | $15.69 | $188K | Direct | Jan 29, 2024 (4d) |
| Dec 26, 2023 | ELVN | ↓ Sell | 12,000 | $14.64 | $176K | Direct | Dec 28, 2023 (2d) |
| Dec 22, 2023 | ELVN | ↓ Sell | 8,195 | $13.05 | $107K | Direct | Dec 26, 2023 (4d) |
| Dec 20, 2023 | ELVN | ↓ Sell | 7,779 | $13.01 | $101K | Direct | Dec 21, 2023 (1d) |
| Nov 3, 2023 | ELVN | ↓ Sell | 8,026 | $13.08 | $105K | Direct | Nov 6, 2023 (3d) |
| Sep 25, 2023 | ELVN | ↓ Sell | 12,000 | $13.81 | $166K | Direct | Sep 26, 2023 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ELVN insiders
Open-market trades in the last 12 months
About Samuel Kintz's insider trades
Samuel Kintz is President and CEO at Enliven Therapeutics (ELVN). Since Sep 25, 2023, Samuel has reported no open-market purchases and 32 sales worth $7.4M on SEC Form 4. In the last 12 months: 1 sale ($273K).
Their filings also include option exercises (11 filings), grants and awards (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ELVN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.